NASDAQ: MURA - Mural Oncology plc

Lønnsomhet i seks måneder: +5.57%
Utbytte: 0.00%

Kampanjeplan Mural Oncology plc

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Mural Oncology plc

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs.

flere detaljer
Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2023-11-16
ISIN IE000LK2BOB4
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.muraloncology.com
Цена ао 4.49
Prisendring per dag: +1.26% (3.18)
Prisendring per uke: +1.26% (3.18)
Prisendring per måned: -20.3% (4.04)
Prisendring over 3 måneder: +5.57% (3.05)
Prisendring over seks måneder: +5.57% (3.05)
Prisendring per år: -45.61% (5.92)
Prisendring over 3 år: 0% (3.22)
Prisendring over 5 år: 0% (3.22)
Prisendring over 10 år: 0% (3.22)
Prisendring siden begynnelsen av året: -4.45% (3.37)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.3745 10
P/E 0 0
EV/EBITDA 0.8176 10
Total: 5

Effektivitet

Navn Betydning Karakter
ROA, % -68.75 0
ROE, % -78.63 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0781 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 10.82 2
Lønnsomhet EPS, % 18.26 3
Total: 2.4
Flere detaljer

Institusjoner Volum Dele, %
Westfield Capital Management Co LP 1985886 11.9
Bank Of New York Mellon Corporation 399462 2.39
PRIMECAP Management Company 256255 1.54
Dimensional Fund Advisors LP 238482 1.43
HRT Financial LP 201934 1.21
Artisan Partners Limited Partnership 185432 1.11
Norges Bank Investment Management 168511 1.01
Charles Schwab Investment Management, Inc. 81208 0.49
PanAgora Asset Management, Inc. 63924 0.38
Connor Clark & Lunn Investment Management Ltd 51162 0.31

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.0142 17.09 1.54048
Schwab 1000 Index ETF 0.0001 25.15 1.42441

Veileder Stillingstittel Betaling Fødselsår
Ms. Caroline J. Loew Ph.D. President, CEO & Director 303.29k 1971 (54 år)
Mr. Adam D. Cutler B.A. CFO, Principal Financial Officer & Principal Accounting Officer 496.65k 1975 (50 år)
Ms. Maiken Keson-Brookes Chief Legal Officer N/A 1973 (52 år)
Mr. Justin Levine Head of Human Resources & VP of Human Resources N/A
Dr. Vicki L. Goodman M.D. Chief Medical Officer 578.34k 1971 (54 år)

Adresse: Ireland, Dublin D T, 10 Earlsfort Terrace - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.muraloncology.com